Published: Feb 14, 2015
The new guidelines of EU in relation to the control of blood pressure for diabetics could raise some problems.
A study done by researchers of The George Institute for Global Health, which is in affiliation to the Oxford Martin School at Oxford University, states that the new guidelines of EU could increase the chances of heart diseases, and/or stroke.
The new guidelines states that the blood pressure level for normal people should be below 140/90mmHg, while for the diabetics the level of blood pressure should kept at the maximum of 130/80mmHg.
Now very long ago another report about these researchers, who now pose a problem with the new guidelines, had provided therapeutic solutions to patients of type 2 diabetes having high blood pressure.
The reason why this new guideline is posing a problem is because high blood pressure in humans generates the risk of heart attacks, stroke and cardiovascular diseases. As for diabetic patients, due to high sugar levels, they already have a high chance of acquiring cardiovascular diseases; and having a high blood pressure will put them at an even higher risk.
The researchers claim that the conclusion of the study was that people who had blood pressure lower than 130mmHg, had 25% lower chance of having any cardiovascular disease; whereas, the patients who had more than 130mmHg, were at higher risk. When analyzing the data, they found that those with low blood pressure reduced the chances of acquiring eye and/or kidney diseases amongst diabetics. They added that relaxing the level of blood pressure could be dangerous.
Professor Kazem Rahimi, the author of the study, said that the news about the change in the guidelines is very unfortunate because they will prove to be harmful to the patients as higher BP would result in more risks of mortality. Rahimi, adds that these new changes should be modified and the BP target should be lowered to 130mmHg from 140mmHg.
Neil Poulter, from Imperial College London agrees with the results of the study and says that this could influence and change the guidelines of the new target set. He adds that changing the guidelines is necessary for the patients to be able to receive timely treatments in the UK and the US.
There are around 2.5 million patients of diabetes in the United Kingdom who are suffering. Diabetes is a diseases which can lead to other diseases like kidney, heart or eye diseases. Changing the guidelines would help the patients receive treatment well in time.
Though Paulter was not a part of the study, he has been worried about the change in the BP targets for the diabetic patients. He believes that this study has provided enough facts to change the new formed rules.